The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
Kobayashi, S., Boggon, T. J., Dayaram, T., Jänne, P. A., Kocher, O., Meyerson, M., Johnson, B. E., Eck, M. J., Tenen, D. G., & Halmos, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044238 · Cited by 3,964
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
Wan, P. T. C., Garnett, M. J., Roe, S. M., Lee, S., Niculescu-Duvaz, D., Good, V. M., Project, C. G., Jones, C. M., Marshall, C. J., Springer, C. J., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00215-6 · Cited by 2,808
Zha, J., Harada, H., Yang, E., Jockel, J., & Korsmeyer, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81382-3 · Cited by 2,595
Regulation of Cell Death Protease Caspase-9 by Phosphorylation
Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S., & Reed, J. C. (1998) · Science · doi:10.1126/science.282.5392.1318 · Cited by 2,481
The protein kinase B/Akt signalling pathway in human malignancy
Nicholson, K. M., & Anderson, N. G. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00271-6 · Cited by 1,639
Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
Sordella, R., Bell, D. W., Haber, D. A., & Settleman, J. (2004) · Science · doi:10.1126/science.1101637 · Cited by 1,606
Protein kinase Cα activates RAF-1 by direct phosphorylation
Kolch, W., Heidecker, G., Kochs, G., Hummel, R., Vahidi, H., Mischak, H., Finkenzeller, G., Marmé, D., & Rapp, U. R. (1993) · Nature · doi:10.1038/364249a0 · Cited by 1,277
RAF/RAS oncogenes and mismatch-repair status
Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K. W., Vogelstein, B., & Velculescu, V. E. (2002) · Nature · doi:10.1038/418934a · Cited by 1,224 · cited 1×
“In some cells, B-Raf mutations are believed to be initiating events and not sufficient for full-blown neoplastic transformation (Rajagopalan et al., 2002; Yuen et al., 2002).”
BackgroundChang, F., Lee, J. T., Navolanic, P. M., Steelman, L. S., Shelton, J. G., Blalock, W. L., Franklin, R. A., & McCubrey, J. A. (2003) · Leukemia · doi:10.1038/sj.leu.2402824 · Cited by 1,176
Self-citationSuppression of Raf-1 kinase activity and MAP kinase signalling by RKIP
Yeung, K., Seitz, T., Li, S., Janosch, P., McFerran, B., Kaiser, C., Fee, F., Katsanakis, K. D., Rose, D. W., Mischak, H., et al. (1999) · Nature · doi:10.1038/43686 · Cited by 893
Garnett, M. J., & Marais, R. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.022 · Cited by 799
Differentiation Stage-Specific Inhibition of the Raf-MEK-ERK Pathway by Akt
Rommel, C., Clarke, B. A., Zimmermann, S., Nuñez, L., Rossman, R., Reid, K., Moelling, K., Yancopoulos, G. D., & Glass, D. J. (1999) · Science · doi:10.1126/science.286.5445.1738 · Cited by 758
Chang, F., Steelman, L. S., Lee, J. T., Shelton, J. G., Navolanic, P. M., Blalock, W. L., Franklin, R. A., & McCubrey, J. A. (2003) · Leukemia · doi:10.1038/sj.leu.2402945 · Cited by 725
Self-citationJAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
Steelman, L. S., Pohnert, S. C., Shelton, J. G., Franklin, R. A., Bertrand, F. E., & McCubrey, J. A. (2004) · Leukemia · doi:10.1038/sj.leu.2403241 · Cited by 684
Self-citationHsp90 inhibitors as novel cancer chemotherapeutic agents
Neckers, L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02316-x · Cited by 677
Woods, D., Parry, D., Cherwinski, H., Bosch, E., Lees, E., & McMahon, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5598 · Cited by 639
Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1.
Alessi, D. R., Saito, Y., Campbell, D. G., Cohen, P., Sithanandam, G., Rapp, U., Ashworth, A., Marshall, C. J., & Cowley, S. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06424.x · Cited by 559
Ras Isoforms Vary in Their Ability to Activate Raf-1 and Phosphoinositide 3-Kinase
Yan, J., Roy, S., Apolloni, A., Lane, A., & Hancock, J. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24052 · Cited by 477
Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK
Allan, L. A., Morrice, N., Brady, S., Magee, G., Pathak, S., & Clarke, P. R. (2003) · Nature Cell Biology · doi:10.1038/ncb1005 · Cited by 474
Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation
Mason, C. S. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2137 · Cited by 457
Raf proteins and cancer: B-Raf is identified as a mutational target
Mercer, K. E., & Pritchard, C. A. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00016-7 · Cited by 457
Mazzucchelli, C., Vantaggiato, C., Ciamei, A., Fasano, S., Pakhotin, P., Krezel, W., Welzl, H., Wolfer, D. P., Pagès, G., Valverde, O., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00716-x · Cited by 456
Differential Regulation of Raf-1, A-Raf, and B-Raf by Oncogenic Ras and Tyrosine Kinases
Marais, R., Light, Y., Paterson, H. F., Mason, C. S., & Marshall, C. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4378 · Cited by 456
FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia
Stirewalt, D. L., Kopecky, K. J., Meshinchi, S., Appelbaum, F. R., Slovak, M. L., Willman, C. L., & Radich, J. P. (2001) · Blood · doi:10.1182/blood.v97.11.3589 · Cited by 431
Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling
Pouysségur, J., Volmat, V., & Lenormand, P. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01135-8 · Cited by 421
Discovery of a novel Raf kinase inhibitor.
Lyons, J. F., Wilhelm, S., Hibner, B., & Bollag, G. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080219 · Cited by 416
Yuen, S. T., Davies, H. R., Chan, T. L., Ho, J. W. C., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Tsui, W. W., Chan, A. S. Y., et al. (2002) · PubMed · Cited by 404
Blagosklonny, M. V., Schulte, T., Nguyen, P., Trepel, J. B., & Neckers, L. (1996) · PubMed · Cited by 375
Activation of Raf-1 by 14-3-3 proteins
Fantl, W. J., Muslin, A. J., Kikuchi, A., Martin, J. A., MacNicol, A. M., Grosst, R. W., & Williams, L. T. (1994) · Nature · doi:10.1038/371612a0 · Cited by 367
Effects of Raf Kinase Inhibitor Protein Expression on Suppression of Prostate Cancer Metastasis
Fu, Z., Smith, P. C., Zhang, L., Rubin, M. A., Dunn, R. L., Yao, Z., & Keller, E. T. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.12.878 · Cited by 364
Corbit, K. C., Trakul, N., Eves, E. M., Diaz, B., Marshall, M., & Rosner, M. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210015200 · Cited by 360
Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase.
Fabian, J. R., Daar, I. O., & Morrison, D. K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.11.7170 · Cited by 353
Apoptosis Meets Signal Transduction: Elimination of a BAD Influence
Gajewski, T. F., & Thompson, C. B. (1996) · Cell · doi:10.1016/s0092-8674(00)81377-x · Cited by 341
Busca, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.2900 · Cited by 326
Role of the Kinase MST2 in Suppression of Apoptosis by the Proto-Oncogene Product Raf-1
O'Neill, E., Rushworth, L., Baccarini, M., & Kolch, W. (2004) · Science · doi:10.1126/science.1103233 · Cited by 317
Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia
Milella, M., Kornblau, S. M., Estrov, Z., Carter, B. Z., Lapillonne, H., Harris, D., Konopleva, M., Zhao, S., Estey, E., & Andreeff, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12807 · Cited by 312
Endothelial apoptosis in Braf-deficient mice
Wojnowski, L., Zimmer, A. M., Beck, T. W., Hahn, H., Bernal, R., Rapp, U. R., & Zimmer, A. (1997) · Nature Genetics · doi:10.1038/ng0797-293 · Cited by 299
Negative Regulation of the Serine/Threonine Kinase B-Raf by Akt
Guan, K.-L., Figueroa, C., Brtva, T. R., Zhu, T., Taylor, J., Barber, T. D., & Vojtek, A. B. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61518-8 · Cited by 281
Regulation of Raf-1 activation and signalling by dephosphorylation
Dhillon, A. S. (2002) · The EMBO Journal · doi:10.1093/emboj/21.1.64 · Cited by 280
Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas
Fransen, K. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh049 · Cited by 268
Paradoxical activation of Raf by a novel Raf inhibitor
Hall-Jackson, C. A., Eyers, P. A., Cohen, P., Goedert, M., Tom Boyle, F., Hewitt, N., Plant, H., & Hedge, P. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80088-x · Cited by 265
CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK)
ALLEN, L. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.012 · Cited by 257
Lee Jr, J., & McCubrey, J. (2002) · Leukemia · doi:10.1038/sj.leu.2402460 · Cited by 251
Self-citationSurvival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases
Deng, X., Ruvolo, P., Carr, B., & May, W. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1578 · Cited by 247
Lin, J., Adam, R. M., Santiestevan, E., & Freeman, M. R. (1999) · PubMed · Cited by 241
Oligomerization activates c-Raf-1 through a Ras-dependent mechanism
Luo, Z., Tzivion, G., Belshaw, P. J., Vavvas, D., Marshall, M., & Avruch, J. (1996) · Nature · doi:10.1038/383181a0 · Cited by 237
Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs
Blagosklonny, M. (2002) · Leukemia · doi:10.1038/sj.leu.2402415 · Cited by 235
Cooperating oncogenes converge to regulate cyclin/cdk complexes.
Lloyd, A. C., Obermüller, F., Staddon, S., Barth, C. F., McMahon, M., & Land, H. (1997) · Genes & Development · doi:10.1101/gad.11.5.663 · Cited by 224
Diaz, B., Barnard, D., Filson, A., MacDonald, S., King, A., & Marshall, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4509 · Cited by 203
Altered states: selectively drugging the Hsp90 cancer chaperone
Workman, P. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.12.005 · Cited by 195
RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)
Flotho, C., Valcamonica, S., Mach-Pascual, S., Schmahl, G., Corral, L., Ritterbach, J., Hasle, H., Aricò, M., Biondi, A., & Niemeyer, C. (1999) · Leukemia · doi:10.1038/sj.leu.2401240 · Cited by 194
McCarthy, S. A., Samuels, M. L., Pritchard, C. A., Abraham, J. A., & McMahon, M. (1995) · Genes & Development · doi:10.1101/gad.9.16.1953 · Cited by 193
Alexia, C., Fallot, G., Lasfer, M., Schweizer-Groyer, G., & Groyer, A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.029 · Cited by 191
Cellular Response to Oncogenic Ras Involves Induction of the Cdk4 and Cdk6 Inhibitor p15INK4b
Malumbres, M., de Castro, I. P., Hernández, M. I., Jiménez, M., Corral, T., & Pellicer, À. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2915-2925.2000 · Cited by 191
Neshat, M. S., Raitano, A. B., Wang, H.-G., Reed, J. C., & Sawyers, C. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1179-1186.2000 · Cited by 185
McCarthy, S. A., Chen, D., Yang, B.-S., Garcia Ramirez, J. J., Cherwinski, H., Chen, X.-R., Klagsbrun, M., Hauser, C. A., Ostrowski, M. C., & McMahon, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2401 · Cited by 163
Pritchard, C. A., Bolin, L., Slattery, R., Murray, R., & McMahon, M. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00548-1 · Cited by 159
Blalock, W., Weinstein-Oppenheimer, C., Chang, F., Hoyle, P., Wang, X.-Y., Algate, P., Franklin, R., Oberhaus, S., Steelman, L., & McCubrey, J. (1999) · Leukemia · doi:10.1038/sj.leu.2401493 · Cited by 158
Self-citationLee, J. T., Steelman, L. S., & McCubrey, J. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1612 · Cited by 156
Self-citationPhosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?
Fry, M. (2001) · Breast Cancer Research · doi:10.1186/bcr312 · Cited by 148
Hindley, A. D., & Kölch, W. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.8.1575 · Cited by 147
Davis, J. M., Navolanic, P. M., Oppenheimer, C. W., Steelman, L. S., Hu, W., Konopleva, M. Y., Blagosklonny, M. V., & McCubrey, J. A. (2003) · PubMed · Cited by 145
Self-citationActivated Raf-1 causes growth arrest in human small cell lung cancer cells.
Ravi, R. K., Weber, E., McMahon, M., Williams, J. R., Baylin, S. B., Mal, A., Harter, M. L., Dillehay, L. E., Claudio, P. P., Giordano, A., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci831 · Cited by 142
Milella, M., Estrov, Z. E., Kornblau, S. M., Carter, B. Z., Konopleva, M. Y., Tari, A. M., Schober, W. D., Harris, D., Leysath, C. E., Lopez‐Berestein, G., et al. (2002) · Blood · doi:10.1182/blood.v99.9.3461 · Cited by 123
Salomoni, P., Wasik, M. A., Riedel, R. F., Reiss, K., Choi, J. K., Skórski, T., & Calabretta, B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.1995 · Cited by 116
Analysis of BRAF Mutation in Primary and Metastatic Melanoma
Libra, M., Malaponte, G., Navolanic, P. M., Gangemi, P., Bevelacqua, V., Proietti, L., Bruni, B., Stivala, F., Mazzarino, M. C., Travali, S., et al. (2005) · Cell Cycle · doi:10.4161/cc.4.10.2026 · Cited by 114
Self-citationRegulation of Bcl2 Phosphorylation and Potential Significance for Leukemic Cell Chemoresistance
Deng, X., Kornblau, S. M., Ruvolo, P. P., & May, W. S. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024254 · Cited by 110
McCubrey, J. A., Steelman, L., Hoyle, P., Blalock, W. L., Oppenheimer, C. W., Franklin, R. A., Cherwinski, H. M., Bosch, E., & McMahon, M. (1998) · Leukemia · doi:10.1038/sj.leu.2401215 · Cited by 110
Self-citationSerum- and Glucocorticoid-inducible Kinase SGK Phosphorylates and Negatively Regulates B-Raf
Zhang, B.-H., Tang, E., Zhu, T., Greenberg, M. E., Vojtek, A. B., & Guan, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102808200 · Cited by 103
The complexity of PTEN: mutation, marker and potential target for therapeutic intervention
Steelman, L. S., Bertrand, F. E., & McCubrey, J. A. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.6.537 · Cited by 102
Self-citationJücker, M., Südel, K. M., Horn, S., Sickel, M. J., Wegner, W., Fiedler, W., & Feldman, R. A. (2002) · Leukemia · doi:10.1038/sj.leu.2402484 · Cited by 97
Hoyle, P., Moye, P. W., Steelman, L., Blalock, W. L., Franklin, R. A., Pearce, M., Cherwinski, H. M., Bosch, E., McMahon, M., & McCubrey, J. A. (2000) · Leukemia · doi:10.1038/sj.leu.2401720 · Cited by 89
Self-citationShelton, J. G., Steelman, L. S., Lee, J. T., Knapp, S. L., Blalock, W. L., Moye, P. W., Franklin, R. A., Pohnert, S. C., Mirza, A. M., McMahon, M., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206321 · Cited by 86
Self-citationOncogenes, growth factors and phorbol esters regulate Raf-1 through common mechanisms
Barnard, D., Diaz, B., Clawson, D. K., & Marshall, M. S. (1998) · Oncogene · doi:10.1038/sj.onc.1202061 · Cited by 86
Basu, A., & Haldar, S. M. (1998) · International Journal of Oncology · doi:10.3892/ijo.13.4.659 · Cited by 81
Overexpression of phosphatidylinositol 3-kinase in human lung cancer
Lin, X., Böhle, A., Dohrmann, P., Leuschner, I., Schulz, A., Kremer, B., & Fändrich, F. (2001) · Langenbeck s Archives of Surgery · doi:10.1007/s004230100203 · Cited by 77
Brummer, T., Shaw, P. E., Reth, M., & Misawa, Y. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf588 · Cited by 77
Raf-1-induced cell cycle arrest in LNCaP human prostate cancer cells
Ravi, R. K., McMahon, M., Yangang, Z., Williams, J. R., Dillehay, L. E., Nelkin, B. D., & Mabry, M. H. (1999) · Journal of Cellular Biochemistry · Cited by 76
Blalock, W. L., Pearce, M., Steelman, L. S., Franklin, R. A., McCarthy, S. A., Cherwinski, H. M., McMahon, M., & McCubrey, J. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203337 · Cited by 75
Self-citationBRAF mutations in non-Hodgkin's lymphoma
Lee, J. W., Yoo, N. J., Soung, Y. H., Kim, H. S., Park, W. S., Kim, S. Y., Lee, J. H., Park, J. Y., Cho, Y. G., Kim, C. J., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601371 · Cited by 68
Self-citationPeyssonnaux, C., Provot, S., Felder‐Schmittbuhl, M., Calothy, G., & Eychène, A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.19.7068-7079.2000 · Cited by 68
Defects in p21WAF1/CIP1, Rb, and c-myc signaling in phorbol ester-resistant cancer cells.
Blagosklonny, M. V., Prabhu, N. S., & El‐Deiry, W. S. (1997) · PubMed · Cited by 66
McCubrey, J. A., Lee, J. T., Steelman, L. S., Blalock, W. L., Moye, P. W., Chang, F., Pearce, M., Shelton, J. G., White, M. K., Franklin, R. A., et al. (2001) · PubMed · Cited by 62
Self-citationP21Cip1 induced by Raf is associated with increased Cdk4 activity in hematopoietic cells
Chang, F., & McCubrey, J. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204564 · Cited by 56
Self-citationShelton, J. G., Steelman, L. S., Abrams, S. L., Bertrand, F. E., Franklin, R. A., McMahon, M., & McCubrey, J. A. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.5.1009 · Cited by 52
Self-citationShelton, J. G., Moye, P. W., Steelman, L. S., Blalock, W. L., Lee, J. T., Franklin, R. A., McMahon, M., & McCubrey, J. A. (2003) · Leukemia · doi:10.1038/sj.leu.2403052 · Cited by 49
Self-citationEffect of the activated Raf protein kinase on the human multidrug resistance 1 (MDR1) gene promoter
Kim, S., Lee, S., Kwak, N.-H., Kang, C., & Chung, B. (1996) · Cancer Letters · doi:10.1016/0304-3835(95)04023-4 · Cited by 46
Miltenberger, R. J., Farnham, P., Smith, D. E., Stommel, J. M., & Cornwell, M. M. (1995) · PubMed · Cited by 45
Antiapoptosis potential of bcl-2 oncogene by dephosphorylation
Haldar, S., Jena, N., & Croce, C. M. (1994) · Biochemistry and Cell Biology · doi:10.1139/o94-061 · Cited by 44
Akula, S. M., Ford, P. W., Whitman, A. G., Hamden, K. E., Bryan, B. A., Cook, P., & McCubrey, J. A. (2005) · Blood · doi:10.1182/blood-2004-09-3683 · Cited by 41
Self-citationBlagosklonny, M. V. (1999) · Leukemia · doi:10.1038/sj.leu.2401623 · Cited by 39
Raf-Induced Cell Cycle Progression in Human TF-1 Hematopoietic Cells
Chang, F., Steelman, L. S., & McCubrey, J. A. (2002) · Cell Cycle · doi:10.4161/cc.1.3.128 · Cited by 38
Self-citationMartínez‐Lorenzo, M. J., Anel, A., Monleón, I., Sierra, J. J., Piñeiro, A., Naval, J., & Álava, M. A. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00142-9 · Cited by 37
Hamden, K. E., Whitman, A. G., Ford, P. W., Shelton, J. G., McCubrey, J. A., & Akula, S. M. (2004) · Leukemia · doi:10.1038/sj.leu.2403532 · Cited by 37
Self-citationRaf promotes human herpesvirus-8 (HHV-8/KSHV) infection
Akula, S. M., Ford, P. W., Whitman, A. G., Hamden, K. E., Shelton, J. G., & McCubrey, J. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207643 · Cited by 34
Self-citationAcoustical Signal Processing in the Central Auditory System
Glendenning, K. K. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01320-4 · Cited by 34
Blagosklonny, M. V. (1998) · International Journal of Cancer · Cited by 33
Chasing Mutations in the Epidermal Growth Factor in Lung Cancer
Dowell, J. E., & Minna, J. D. (2005) · New England Journal of Medicine · doi:10.1056/nejme058033 · Cited by 32
Shelton, J. G., Steelman, L. S., Abrams, S. L., White, E. R., Akula, S. M., Franklin, R. A., Bertrand, F. E., McMahon, M., & McCubrey, J. A. (2005) · Cell Cycle · doi:10.4161/cc.4.6.1724 · Cited by 27
Self-citationBinding activity of H-Ras is necessary for in vivo inhibition of ASK1 activity
Du, J., Cai, S. H., Shi, Z., & Nagase, F. (2004) · Cell Research · doi:10.1038/sj.cr.7290214 · Cited by 25
Lee, J., Steelman, L. S., & McCubrey, J. A. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.6.1637 · Cited by 25
Self-citationHamden, K. E., Ford, P. W., Whitman, A. G., Dyson, O. F., Cheng, S., McCubrey, J. A., & Akula, S. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13381-13390.2004 · Cited by 23
Self-citationTo be or not to be: a question of B-Raf?
Kölch, W. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01889-0 · Cited by 14
Cited by
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Wong, E. W. T., Chang, F., Lehmann, B., Terrian, D. M., Milella, M., Tafuri, A., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.10.001 · Cited by 2,284
Self-citationPI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Glaviano, A., Foo, A. S. C., Lam, H. Y., Yap, K. C. H., Jacot, W., Jones, R. H., Eng, H., Nair, M. G., Makvandi, P., Geoerger, B., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01827-6 · Cited by 2,138
Asati, V., Mahapatra, D. K., & Bharti, S. K. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.01.012 · Cited by 612
Anti-cancer chalcones: Structural and molecular target perspectives
Mahapatra, D. K., Bharti, S. K., & Asati, V. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.05.004 · Cited by 495
Abou-Alfa, G. K., Johnson, P., Knox, J. J., Capanu, M., Davidenko, I., Lacava, J., Leung, T., Gansukh, B., & Saltz, L. B. (2010) · JAMA · doi:10.1001/jama.2010.1672 · Cited by 448
Metadata
- Authors
- McCubrey, J. A., Steelman, L. S., Abrams, S. L., Lee, J. T., Chang, F., Bertrand, F. E., Navolanic, P. M., Terrian, D. M., Franklin, R. A., D’Assoro, A. B., Salisbury, J. L., Mazzarino, M. C., Stivala, F., & Libra, M.
- Venue
- Advances in Enzyme Regulation
- Publisher
- Elsevier BV
- Published
- 2006
- Volume
- 46
- Issue
- 1
- Pages
- 249-279
- ISSN
- 0065-2571 (ISSN-L)
- OpenAlex
- W2081673273
- Cited by
- 664
- References
- 105
- FWCI
- 9.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.